title: Analysis of hemoglobin adducts from acrylamide, glycidamide, and ethylene oxide in paired mother/cord blood samples from Denmark.
abstract: The knowledge about fetal exposure to acrylamide/glycidamide from the maternal exposure through food is limited. Acrylamide, glycidamide, and ethylene oxide are electrophiles and form adducts with hemoglobin (Hb), which could be used for in vivo dose measurement. In this study, a method for analysis of Hb adducts by liquid chromatography-mass spectrometry, the adduct FIRE procedure, was applied to measurements of adducts from these compounds in maternal blood samples (n = 87) and umbilical cord blood samples (n = 219). The adduct levels from the three compounds, acrylamide, glycidamide, and ethylene oxide, were increased in tobacco smokers. Highly significant correlations were found between cord and maternal blood with regard to measured adduct levels of the three compounds. The mean cord/maternal hemoglobin adduct level ratios were 0.48 (range 0.27-0.86) for acrylamide, 0.38 (range 0.20-0.73) for glycidamide, and 0.43 (range 0.17-1.34) for ethylene oxide. In vitro studies with acrylamide and glycidamide showed a lower (0.38-0.48) rate of adduct formation with Hb in cord blood than with Hb in maternal blood, which is compatible with the structural differences in fetal and adult Hb. Together, these results indicate a similar life span of fetal and maternal erythrocytes. The results showed that the in vivo dose in fetal and maternal blood is about the same and that the placenta gives negligible protection of the fetus to exposure from the investigated compounds. A trend of higher levels of the measured adducts in cord blood with gestational age was observed, which may reflect the gestational age-related change of the cord blood Hb composition toward a higher content of adult Hb. The results suggest that the Hb adduct levels measured in cord blood reflect the exposure to the fetus during the third trimester. The evaluation of the new analytical method showed that it is suitable for monitoring of background exposures of the investigated electrophilic compounds in large population studies.
authors: Department of Materials and Environmental Chemistry, Environmental Chemistry Unit, Arrhenius Laboratory, Stockholm University, SE-106 91 Stockholm, Sweden.
authors: Hans
authors: H
authors: von Stedingk
authors: Anna C
authors: AC
authors: Vikström
authors: Per
authors: P
authors: Rydberg
authors: Marie
authors: M
authors: Pedersen
authors: Jeanette K S
authors: JK
authors: Nielsen
authors: Dan
authors: D
authors: Segerbäck
authors: Lisbeth E
authors: LE
authors: Knudsen
authors: Margareta
authors: M
authors: Törnqvist
mesh_terms: D020106:Acrylamide / Q000097:blood*; D000328:Adult; D016022:Case-Control Studies; D002853:Chromatography, Liquid; D003718:Denmark; D004852:Epoxy Compounds / Q000097:blood*; D005027:Ethylene Oxide / Q000097:blood*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005333:Fetus; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D013058:Mass Spectrometry; D018811:Maternal Exposure; D010920:Placenta / Q000502:physiology; D011247:Pregnancy; D012907:Smoking / Q000009:adverse effects / Q000097:blood*
chemical_list: D004852:Epoxy Compounds; D006454:Hemoglobins; D020106:Acrylamide; C071834:glycidamide; D005027:Ethylene Oxide